Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 11

Showing 11 citing articles:

Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection
Fuyun Chi, Chuanjing Cheng, Man Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 332, pp. 118353-118353
Closed Access | Times Cited: 11
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Discovery of β-amino acid substituted naphthalene sulfonamide derivatives as potent Kelch-like ECH-associated protein 1−nuclear factor erythroid 2-related factor 2 (Keap1−Nrf2) protein−protein interaction inhibitors for ulcerative colitis management
Ziquan Zhao, Hongjin Lu, Junjie Wang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117384-117384
Closed Access
A Keap1-recruiting BRD4 Degrader Offers a Single-molecular Polypharmacology Approach for the Treatment of Metabolic Dysfunction-associated Steatohepatitis
Xian Zhang, Yuxin Ge, Mengjie Ye, et al.
Free Radical Biology and Medicine (2025) Vol. 232, pp. 15-27
Closed Access
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 14
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors
Kazuki Otake, Yoshinori Hara, Minoru Ubukata, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3741-3763
Closed Access | Times Cited: 2
Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 1
Improving anti-oxidant stress treatment of subarachnoid hemorrhage through self-assembled nanoparticles of oleanolic acid
Youdong Zhou, Hengyu Wang, Xinyi Zhu, et al.
Drug Delivery (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Genetically supported causal genes for rheumatoid arthritis: Mendelian randomization and co‐localization analyses
Yuanyuan Niu, Fan Su, Simin Chen, et al.
Rheumatology & autoimmunity (2024)
Open Access
Cyclic vinyl sulfones activate NRF2 to protect from oxidative stress-induced programmed necrosis
Pavel B. Davidovich, D. N. Nikolaev, Raniya Khadiullina, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130058-130058
Closed Access
Page 1

Scroll to top